Department of Population Sciences, City of Hope Comprehensive Cancer Center, Duarte, California, USA.
Department of Biostatistics, Medical College of Wisconsin, Milwaukee, Wisconsin, USA.
Oncologist. 2021 Dec;26(12):e2302-e2305. doi: 10.1002/onco.13928. Epub 2021 Aug 26.
Genomic testing of somatic and germline DNA has transformed cancer care. However, low genetic knowledge among patients may compromise care and health outcomes. Given the rise in genomic testing, we sought to understand patients' knowledge of their genetic test results.
We conducted a survey-based study with 85 patients at a comprehensive cancer center. We compared self-reported recall of (a) having had somatic/germline testing and (b) their specific somatic/germline results to the genomic test results documented in the medical record.
Approximately 30% of patients did not recall having had testing. Of those who recalled having testing, 44% of patients with pathogenic/likely pathogenic germline mutations and 57% of patients with reported somatic alterations did not accurately recall their specific gene or variant-level results.
Given significant knowledge gaps in patients' recall of genomic testing, there is a critical need to improve patient-directed education and return-of-results strategies.
体细胞和种系 DNA 的基因组检测改变了癌症的治疗方式。然而,患者的遗传知识水平较低可能会影响治疗效果和健康结局。鉴于基因组检测的增多,我们试图了解患者对其遗传检测结果的了解程度。
我们在一家综合性癌症中心对 85 名患者进行了一项基于调查的研究。我们将(a)患者报告的体细胞/种系检测和(b)他们的特定体细胞/种系检测结果与病历中记录的基因组检测结果进行了比较。
大约 30%的患者不记得接受过检测。在那些记得接受过检测的患者中,44%的种系致病性/可能致病性突变患者和 57%的报告体细胞改变患者无法准确回忆起他们特定的基因或变异水平结果。
鉴于患者对基因组检测的回忆存在显著的知识差距,因此迫切需要改进面向患者的教育和检测结果报告策略。